支架蛋白NEDD9对慢性淋巴细胞白血病小鼠模型中白血病细胞迁移及疾病进展的必要性
在慢性淋巴细胞白血病(CLL)小鼠模型中,全身或B细胞特异性敲除Nedd9可延缓CLL发生、显著降低疾病负荷并带来显著生存获益。NEDD9为CLL细胞归巢、趋化、迁移和黏附所必需。CLL患者外周血NEDD9表达与黏附、迁移特征及白细胞计数相关,淋巴结常高表达NEDD9。
要点
- 小鼠模型中敲除Nedd9可延缓CLL发生并显著降低疾病负荷,带来显著生存获益。
- NEDD9为CLL细胞归巢、趋化、迁移和黏附所必需。
- 抑制AURKA和HDAC6可有效减少CLL细胞迁移和趋化。
核心结论
- 研究提供证据表明NEDD9通过涉及黏附、迁移和归巢的内在缺陷在CLL发病机制中发挥功能性作用。
研究设计与样本
- 在慢性淋巴细胞白血病(CLL)小鼠模型中进行全身或B细胞特异性Nedd9敲除实验。
- 分析CLL患者外周血NEDD9表达与黏附、迁移特征及白细胞计数的关联。
- 检测CLL淋巴结NEDD9表达水平及增殖中心分布。
- 使用AURKA和HDAC6活性阻断剂处理CLL细胞,评估迁移和趋化。
主要发现
- 全身或B细胞特异性敲除Nedd9的CLL小鼠模型显示CLL发生延迟、疾病负荷显著降低并获显著生存获益。
- NEDD9为CLL细胞高效归巢、趋化、迁移和黏附所必需。
- CLL患者外周血NEDD9表达与黏附、迁移特征及白细胞计数相关。
- CLL淋巴结常高表达NEDD9,部分患者NEDD9表达富集于CLL增殖中心。
- 阻断AURKA和HDAC6活性可有效减少CLL细胞迁移和趋化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The scaffold protein NEDD9 is frequently upregulated and hyperphosphorylated in cancers, and is associated with poor clinical outcome. NEDD9 promotes B-cell adhesion, migration and chemotaxis, pivotal processes for malignant development. We show that global or B-cell-specific deletion of Nedd9 in chronic lymphocytic leukemia (CLL) mouse models delayed CLL development, markedly reduced disease burden and resulted in significant survival benefit. NEDD9 was required for efficient CLL cell homing, chemotaxis, migration and adhesion. In CLL patients, peripheral NEDD9 expression was associated with adhesion and migration signatures as well as leukocyte count. Additionally, CLL lymph nodes frequently expressed high NEDD9 levels, with a subset of patients showing NEDD9 expression enriched in the CLL proliferation centers. Blocking activity of prominent NEDD9 effectors, including AURKA and HDAC6, effectively reduced CLL cell migration and chemotaxis. Collectively, our study provides evidence for a functional role of NEDD9 in CLL pathogenesis that involves intrinsic defects in adhesion, migration and homing.
引用
- Rusyn L, Reinartz S, Nikiforov A, et al. The scaffold protein NEDD9 is necessary for leukemia-cell migration and disease progression in a mouse model of chronic lymphocytic leukemia. Leukemia. 2022. PMID: 35523865. doi:10.1038/s41375-022-01586-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。